CHGA and type 2 diabetes mellitus: In comparison of patients with prediabetes (n = 3) with the other patients with obesity without T2D (n = 12) no differences were seen in the numbers of immunopositive cells (chromogranin A, GLP‐1, or serotonin) or NmU areas.